Biofil Chemicals & Pharmaceuticals informs about quarterly statement on investor complaints

08 Apr 2016 Evaluate

Biofil Chemicals & Pharmaceuticals has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Biofil Chem & Pharma Share Price

62.45 1.67 (2.75%)
10-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1510.00
Dr. Reddys Lab 6089.30
Cipla 1533.80
Zydus Lifesciences 1082.55
Lupin 1630.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.